Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
08/2002
08/22/2002US20020115670 1-Aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
08/22/2002DE10108215A1 Pharmazeutische Kombination von Antagonisten von Angiotensin II und Hemmern von Angiotensin II konvertierendem Enzym A pharmaceutical combination of antagonists of angiotensin II inhibitors and angiotensin II converting enzyme
08/22/2002DE10105628A1 Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Benzimidazole derivatives, processes for their preparation and their use as medicaments
08/21/2002CN1365356A Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
08/20/2002US6437147 For therapy of diseases of central nervous system, peripheral nervous system, cardiovascular system, pulmonary system, gastrointestinal system and endocrinological system
08/20/2002US6436978 For preventing or treating disorders modulated by alpha-2 adrenoceptors
08/20/2002US6436941 Treating schizophrenia, depression, and parkinson's disease; side effect reduction
08/20/2002CA2052041C Benzimidazole derivatives, their preparation and use
08/15/2002WO2002062796A1 Epindolidione pigments
08/15/2002WO2002062785A1 Benzimidazole derivatives, method for their production and use thereof as tryptase inhibitors
08/15/2002WO2002062780A2 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
08/15/2002WO2002062766A2 Melanocortin-4 receptor binding compounds and methods of use thereof
08/15/2002WO2002062762A2 Potassium channel openers
08/15/2002WO2002062290A2 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
08/15/2002US20020111497 Reacting azolide salts with phosgene in an aromatic compound or an ether as solvent
08/15/2002US20020111373 Thiadiazolidin-2,4-dione compound
08/15/2002US20020111372 Fused heteroaromatic glucokinase activators
08/15/2002US20020111368 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
08/15/2002CA2437405A1 Potassium channel openers
08/15/2002CA2435820A1 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
08/14/2002CN1364168A Hydrochloride of fused-heterocycle compound
08/13/2002US6433199 Quinone derivatives
08/13/2002US6433188 Fused heteroaromatic glucokinase activators
08/13/2002US6433009 Treatment of autoimmune, cardiovascular, nervous system, gastrointestinal, respiratory system, and viral disorders; antidiabetic, antiarthritic, antiinflammatory and antidepressant agents
08/13/2002US6432995 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor from cells
08/13/2002US6432993 Substituted fused heterocyclic compound
08/13/2002US6432962 Antiinflammatory agents
08/13/2002US6432958 2-piperazinoalkylaminobenzoazole derivatives: dopamine receptor subtype specific ligands
08/13/2002US6432656 Detection of calcilytic compound for calcium receptor bearing cell
08/08/2002WO2002060879A2 Bacterial gyrase inhibitors and uses thereof
08/08/2002WO2002060878A1 Benzimidazolidinone derivatives
08/08/2002WO2002060858A1 Novel compound having maillard reaction inhibitory activity
08/08/2002WO2002060374A2 Benz-1,3-azole derivatives and their uses as heparanase inhibitors
08/08/2002WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
08/08/2002US20020107396 3-cycloalkyl- or propyl-2-(3,4-dihalophenyl)-N-quinolinyl-, quinazolinyl-, or quinoxolinyl-propionamide.
08/08/2002US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
08/08/2002US20020107269 Inhibiting cell proliferation and treating cancer
08/08/2002US20020107263 Squaric acid derivatives
08/08/2002US20020107204 Protease-activated receptor-1 or 2 (PAR-1, PAR-2)
08/07/2002EP1229023A1 Thioimidazolidine derivatives as oil-soluble additives for lubricating oils
08/07/2002CN1362951A Dihetero-substituted metalloprotease inhibitors
08/07/2002CN1088709C Amine compound and its acid addition salt
08/07/2002CN1088702C Disubstituted bicyclic heterocycles, their production and use as medicaments
08/01/2002WO2002059110A1 Pyrimidineamines as angiogenesis modulators
08/01/2002WO2002058704A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors
08/01/2002WO2002042278A3 Imidazole and benzimidazole caspase inhibitors and uses thereof
08/01/2002WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands
08/01/2002US20020103241 Such as N-benzooxazol-2-yl-3-cyclopentyl-2-(4-methanesulfonyl -phenyl)-propionamide for increasing insulin secretion in the treatment of type II diabetes
08/01/2002US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
08/01/2002US20020103232 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
08/01/2002US20020103208 Useful in treatment of anxiety disorders, affective disorders such as depression, psychosis and schizophrenia, Parkinson's disease
08/01/2002US20020103199 Fused heteroaromatic glucokinase activators
08/01/2002US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone
08/01/2002US20020102597 Methods for selecting compounds for treating ischemia-related cellular damage
08/01/2002CA2434558A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors
07/2002
07/31/2002EP1227144A1 Oil-soluble additive compositions for lubricating oils comprising imidazolidine thione
07/31/2002EP1226125A2 Method for producing therapeutic agents for ulcers
07/31/2002EP1226124A1 Heterocyclically substituted benzoylguanidine, method for the production thereof, the use thereof as a medicament or means of diagnosis and a medicament containing the same
07/31/2002EP1060165A4 Method for preparing n-substituted heterocyclic derivatives using a phase-transfer catalyst
07/31/2002CN1361101A New synthesis route of candixatan ester
07/30/2002US6426349 Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia
07/25/2002WO2002057216A1 Terphenyl compounds bearing substituted amino groups
07/25/2002WO2002057215A2 Sodium channel modulators
07/25/2002WO2002056681A2 Novel intermediates and process to pyrimidinedione herbicides
07/25/2002WO2002032422A3 Ep4 receptor inhibitors to treat rheumatoid arthritis
07/25/2002US20020099222 Heterocyclically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them
07/25/2002US20020099208 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
07/25/2002US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases
07/25/2002US20020099074 Novel anilide compounds and drugs containing the same
07/25/2002US20020099054 2-phenyl benzimidazole derivatives as MCP-1 antagonists
07/25/2002US20020099050 E.g., 1-(1,4-benzodioxan-5-ylcarbonyl)-1,2,3,6-tetrahydro-pyridine), 1-(1,3-benzodioxol-5-ylcarbonyl)-piperidine); and 1-(1,3-benzodioxol-5-ylcarbonyl)-1,2,3,6-tetrahydropyridine
07/25/2002US20020098242 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
07/24/2002EP0946203B1 Tricyclic functional dyes for contrast enhancement in optical imaging
07/24/2002CN1360580A Substd. benzoyl ketones, methods for producing them and their use as herbicides
07/24/2002CN1088061C Dihalopropene compounds, insecticidal/acaricidal agent contg. same, and intermediates
07/23/2002US6423737 Benzamidoxime prodrugs as antipneumocystic agents
07/23/2002US6423736 Administering benzimidazole compound
07/23/2002US6423735 Administering benzimidazole compound
07/23/2002US6423699 Contraceptives
07/23/2002US6423698 Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia
07/18/2002WO2002024661A3 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
07/18/2002WO2002012224A3 Bicyclic compounds as h3 receptor ligands
07/18/2002WO2001096299A3 Indole derivatives and their use as 15-lipoxygenase inhibitors
07/18/2002WO2001072715A3 N-halamine vinyl compounds and their polymeric biocides
07/18/2002US20020095039 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
07/18/2002US20020094997 Polymorphs of telmisartan
07/18/2002US20020094963 Benzimidazole derivatives
07/18/2002US20020094936 Fungicidal activity
07/18/2002US20020094453 Metal coordination compound, luminescence device and display apparatus
07/17/2002EP1222187A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases
07/17/2002EP1222163A1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds
07/17/2002CN1087740C New benzimidzole, benzoxazole and benzothiazole compounds, process for their preparation and pharmaceutical compositions containing them
07/16/2002US6420560 H1—histamine receptor antagonists
07/16/2002US6420558 Aminopiperidine derivates as integrin αvβ3 antagonists
07/16/2002US6420411 Compounds and methods for use thereof in the treatment of cancer or viral infections
07/16/2002US6420409 Benzimidazole derivatives
07/16/2002US6420396 Biphenyl and biphenyl-analogous compounds as integrin antagonists
07/16/2002CA2119511C Benzimidazole compounds, their use and preparation
07/11/2002WO2002032877A3 Process for preparation of n-substituted 2-sulfanylimidazoles
07/11/2002WO2002026716A3 Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 154